CN Patent
CN111450076A — 一种Lemborexant软胶囊组合物及其制备方法
Assigned to ANHUI HEAL STAR PHARMACEUTICAL Co.,Ltd. · Expires 2020-07-28 · 6y expired
What this patent protects
本发明公开了一种Lemborexant的软胶囊组合物及其制备方法,由液体或半液体内容物和囊壳组成,其中内容物由Lemborexant、明胶及甘油组成的凝胶状组合物,囊壳由明胶、甘油、水及遮光剂组成。本发明的软胶囊,可直接吸收,有效解决了溶解不均衡,个体差异大导致的疗效差异大的缺点,可安全稳定地口服给药。
USPTO Abstract
本发明公开了一种Lemborexant的软胶囊组合物及其制备方法,由液体或半液体内容物和囊壳组成,其中内容物由Lemborexant、明胶及甘油组成的凝胶状组合物,囊壳由明胶、甘油、水及遮光剂组成。本发明的软胶囊,可直接吸收,有效解决了溶解不均衡,个体差异大导致的疗效差异大的缺点,可安全稳定地口服给药。
Drugs covered by this patent
- Dayvigo (LEMBOREXANT) · Eisai
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.